Φορτώνει......
Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer’s disease
BACKGROUND: Despite substantial research and development investment in Alzheimer’s disease (AD), effective therapeutics remain elusive. Significant emerging evidence has linked cholesterol, β-amyloid and AD, and several studies have shown a reduced risk for AD and dementia in populations treated wit...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Alzheimers Res Ther |
|---|---|
| Κύριοι συγγραφείς: | , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
BioMed Central
2017
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5316146/ https://ncbi.nlm.nih.gov/pubmed/28212683 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-017-0237-y |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|